Literature DB >> 3179613

[3H]-(+)-N-methyl-4-methyldiphenhydramine, a quaternary radioligand for the histamine H1-receptor.

J M Treherne1, J M Young.   

Abstract

1. A series of derivatives of 4-methyldiphenhydramine have been examined as potential quaternary radioligands for the histamine H1-receptor. 2. [3H]-(+)-N-methyl-4-methyldiphenhydramine ([3H]-QMDP), 83 Ci mmol-1, was synthesized by methylation of the tertiary analogue and purified by high-voltage electrophoresis. 3. [3H]-QMDP bound to H1-receptors in a washed homogenate from guinea-pig cerebellum with an affinity constant, Ka, of 1.14 +/- 0.03 x 10(9) M-1. The proportion of non-specific binding of 0.3-0.6 nM [3H]-QMDP, defined by 0.4 microM mepyramine, was usually in the range 15-45%, depending on the method of measurement of binding. The affinity of [3H]-QMDP was similar in guinea-pig cerebellum, cerebral cortex and hippocampus, but was lower, 1.4 x 10(8) M-1, in rat cerebral cortex. 4. Evidence was obtained for the presence of a secondary, non-muscarinic, binding site for [3H]-QMDP in guinea-pig cerebellum, approximate Ka 1.5 x 10(7) M-1, accounting for circa 4% of the total binding of 1 nM [3H]-QMDP. 5. There was a very good correlation between the affinities of 15 compounds for the H1-receptor determined from inhibition of [3H]-QMDP binding and from inhibition of [3H]-mepyramine binding. 6. The potential utility of [3H]-QMDP for studies of H1-receptors in the plasma membrane of cells in culture is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3179613      PMCID: PMC1854022          DOI: 10.1111/j.1476-5381.1988.tb11591.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Heterogeneity of histamine H1-receptors: species variations in [3H]mepyramine binding of brain membranes.

Authors:  R S Chang; V T Tran; S H Snyder
Journal:  J Neurochem       Date:  1979-06       Impact factor: 5.372

2.  Characterization of [3H]mepyramine binding to the longitudinal muscle of guinea pig small intestine.

Authors:  S J Hill; J M Young
Journal:  Mol Pharmacol       Date:  1981-05       Impact factor: 4.436

3.  The binding of [3H]mepyramine to histamine H1 receptors in guinea-pig brain.

Authors:  S J Hill; P C Emson; J M Young
Journal:  J Neurochem       Date:  1978-10       Impact factor: 5.372

4.  Specific binding of 3H-mepyramine to histamine H1 receptors in intestinal smooth muscle.

Authors:  S J Hill; J M Young; D H Marrian
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

5.  Antagonism of central histamine H1 receptors by antipsychotic drugs.

Authors:  S J Hill; M Young
Journal:  Eur J Pharmacol       Date:  1978-12-01       Impact factor: 4.432

6.  Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine.

Authors:  V T Tran; R S Chang; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

7.  The binding of doxepin to histamine H1-receptors in guinea-pig and rat brain.

Authors:  J Aceves; S Mariscal; K E Morrison; J M Young
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

8.  High-affinity binding of [3H]doxepin to histamine H1-receptors in rat brain: possible identification of a subclass of histamine H1-receptors.

Authors:  J E Taylor; E Richelson
Journal:  Eur J Pharmacol       Date:  1982-03-12       Impact factor: 4.432

9.  Histamine H1-receptors in the brain of the guinea-pig and the rat: differences in ligand binding properties and regional distribution.

Authors:  S J Hill; J M Young
Journal:  Br J Pharmacol       Date:  1980-04       Impact factor: 8.739

10.  [3H]doxepin interactions with histamine H1-receptors and other sites in guinea pig and rat brain homogenates.

Authors:  V T Tran; R Lebovitz; L Toll; S H Snyder
Journal:  Eur J Pharmacol       Date:  1981-04-09       Impact factor: 4.432

View more
  9 in total

1.  Kinetics of antagonism at histamine-H1 receptors in isolated rabbit arteries.

Authors:  H O Onaran; T A Bökesoy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

2.  Histamine-induced inositol phosphate accumulation in HeLa cells: lithium sensitivity.

Authors:  D R Bristow; J A Arias-Montaño; J M Young
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

3.  Proceedings of the British Pharmacological Society. Leeds, 12th-14th July 1989. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

4.  Inhibition by cations of antagonist binding to histamine H1-receptors: differential effect of sodium ions on the binding of two radioligands.

Authors:  J M Treherne; J S Stern; W J Flack; J M Young
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

5.  gamma-Aminobutyric acid inhibition of histamine-induced inositol phosphate formation in guinea-pig cerebellum: comparison with guinea-pig and rat cerebral cortex.

Authors:  M L Crawford; H Carswell; J M Young
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

6.  Desensitization of histamine H1 receptor-mediated inositol phosphate accumulation in guinea pig cerebral cortex slices.

Authors:  D R Bristow; P C Banford; I Bajusz; A Vedat; J M Young
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Temperature-dependence of the kinetics of the binding of [3H]-(+)-N-methyl-4-methyldiphenhydramine to the histamine H1-receptor: comparison with the kinetics of [3H]-mepyramine.

Authors:  J M Treherne; J M Young
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

8.  Barbiturates inhibit ATP-K+ channels and voltage-activated currents in CRI-G1 insulin-secreting cells.

Authors:  R Z Kozlowski; M L Ashford
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

9.  Characteristics of the binding of [3H]-mepyramine to intact human U373 MG astrocytoma cells: evidence for histamine-induced H1-receptor internalisation.

Authors:  S Hishinuma; J M Young
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.